Monares, Xever Kiel .
HRN: 23-43-84 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2024
MUPIROCIN 2%, 15G (TUBE)
01/21/2024
01/26/2024
APPLY ON SKIN
Thin Layer
BID
Varicella Zoster Rashes
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes